ClinicalTrials.gg
TerminatedNCT06924957HRAMpositionUpdated Aug 19, 2026

Influence of Body Position on the Defecation Model During Anorectal Manometry.

An observational study in Constipation, Children and Anorectal Disorder, sponsored by Medical University of Warsaw. Terminated at 1 site in Poland. Open to participants aged 4 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-19.

Sponsored by Medical University of Warsaw · Observational

Why this study was terminated
Low rate of enrolment of patients in control group
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
84
Ages
4 Years to 18 Years
Sex
All
01

Study summary

Anorectal 3D manometry (3D HRAM) is the most advanced version of manometric equipment that measures pressures along the anal canal in a very detailed manner. It provides complete data about pressure profile of anorectum and may indicate impaired defecation dynamics. Resent studies suggest that the position in which 3D HRAM is performed should be changed. So far, no scientific research has been performed in children that directly compares both positions. The reference values of registered pressures during 3D HRAM in people without complaints were not specified, which would allow for a more precise diagnosis of patients with an incorrect defecation model and precise selection of patients who could benefit from biofeedback therapy.

Read the detailed description

Patients with the diagnosis of constipation will be enrolled in the study. Each patient will be investigated by anorectal manometry in both- sitted and lying position.

During anorectal manometry conventional manometric parameters will be recorded, such as resting pressure, squeeze pressure, bear down manoeuver, thresholds of sensation and threshold of recto anal inhibitory reflex. 3D picture of anal canal will be recorded.

02

Conditions studied

  • Constipation
  • Children
  • Anorectal Disorder

Keywords

  • anorectal manometry
  • HRAM
  • constipasion
  • position
03

In context

Constipation

1,046 studies on the registry are indexed under Constipation; 161 are open to participants now.

This study's enrollment of 84 is below the median of 120 across 126 observational studies indexed under Constipation.

Browse Constipation studies →

Lead sponsor

Medical University of Warsaw is the lead sponsor of 326 studies on the registry; 87 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The sample size was calculated to detect a 45% difference in the percentage of patients with a negative rectoanal gradient, assuming equal groups, alpha = 0.05, beta = 0.1, and a 30% drop out percentage. There should be 30 people in the constipation group and 30 healthy volunteers.

Due to possible differences depending on age, it was decided to conduct the study in two separate age groups (I. younger, i.e. 5-10 years old and II. older, 11-18 years old). The total number of patients in the study will therefore be 120 people.

Eligibility criteria

Inclusion criteria - the study group:

  • age from 5 to 18 years old
  • functional constipation diagnosed on the basis of Rome IV criteria
  • parental or guardian written consent to the participation of the child in the study; in the case of a child ≥16 years old also the child's written consent

Inclusion criteria - the control group:

  • age from 5 to 18 years old
  • no lower gastrointestinal symptoms
  • parental or guardian written consent to the participation of the child in the study; in the case of a child ≥16 years old also the child's written consent

Exclusion criteria - the study group and the control group:

  • undergone surgeries due to congenital anomalies in the lower gastrointestinal tract
  • inflammatory bowel diseases or inflammation of the large intestine with a different aetiology
  • anal fissure, inflammation of the anal area or other conditions which, in the opinion of the researcher, could affect the functioning of the distal gastrointestinal tract
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
84 participants (actual)
Target follow-up
1 Week
Patient registry
Yes

Groups and cohorts

  • Constipation group

    Children that meet Rome IV criteria to diagnose functional constipation.

    Other: 3D HRAM

  • Healthy volounteers

    Children without IBD, without chronic diseases of GI tract nor history of anorectal surgery

    Other: 3D HRAM

Interventions

  • Other3D HRAM

    The test will be performed both in supine and sitting position successively, using 3D HR-ARM. Resting, squeeze pressures, and bear down manoeuvre variables will be obtained. Diagnosis of dyssynergic defecation requires \< 20% relaxation of anal sphincter and/or intrarectal pressure\>40 mmHg during bear down manoeuvre.

    Also known as: Three-dimensional high-resolution anorectal manometry

06

What researchers measure

Primary outcomes

  1. DD frequency

    The difference in the number of patients with DD (defined as \<20% relaxation of anal sphincter and/or intrarectal pressure \>40 mmHg during bear down manoeuvre) in sitting and lying position.

    Time frame: 1 day

Secondary outcomes

  1. Values of pressures obtained during anorectal manometry

    Values of manometric parameters obtained in the lying and sitting position: mean resting pressure of the anal sphincter (mmHg), maximum squeeze pressure (mmHg), residual anal pressure (mmHg).

    Time frame: 1 day

  2. Values of mean anal canal length

    The mean anal canal length will be assessed in sitting and lying position in the two groups.

    Time frame: 1 day

  3. Percentage of anal relaxation rate

    the assessment of parameters of defecation dynamics during HR-ARM: rectoanal pressure gradient. All secondary end points will be assessed in sitting and lying position in the two groups. the assessment of parameters of defecation dynamics during HR-ARM: percentage of anal relaxation rate, rectoanal pressure gradient. All secondary

    Time frame: 1 day

07

Study locations

1 site
  • The Department of Paediatric Gastroenterology and Nutrition, Warsaw Medical University
    Warsaw, Masovian Voivodeship 02-091, Poland
08

References and documents

Publications

  • Rao SS, Kavlock R, Rao S. Influence of body position and stool characteristics on defecation in humans. Am J Gastroenterol. 2006 Dec;101(12):2790-6. doi: 10.1111/j.1572-0241.2006.00827.x. Epub 2006 Oct 6. PubMed 17026568 ↗
  • Su H, Peng LH, Sun G, Yang YS, Wu J, Jiang GJ, Ge H. Effect of different body position on anorectal manometry for chronic constipation patients. Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8493-8500. doi: 10.26355/eurrev_201910_19162. PubMed 31646580 ↗
  • Wu GJ, Xu F, Lin L, Pasricha PJ, Chen JDZ. Anorectal manometry: Should it be performed in a seated position? Neurogastroenterol Motil. 2017 May;29(5). doi: 10.1111/nmo.12997. Epub 2016 Dec 1. PubMed 27910245 ↗
  • Coss-Adame E, Rao SS, Valestin J, Ali-Azamar A, Remes-Troche JM. Accuracy and Reproducibility of High-definition Anorectal Manometry and Pressure Topography Analyses in Healthy Subjects. Clin Gastroenterol Hepatol. 2015 Jun;13(6):1143-50.e1. doi: 10.1016/j.cgh.2014.12.034. Epub 2015 Jan 20. PubMed 25616028 ↗
  • Grossi U, Carrington EV, Bharucha AE, Horrocks EJ, Scott SM, Knowles CH. Diagnostic accuracy study of anorectal manometry for diagnosis of dyssynergic defecation. Gut. 2016 Mar;65(3):447-55. doi: 10.1136/gutjnl-2014-308835. Epub 2015 Mar 12. PubMed 25765461 ↗
  • Skowronska B, Banaszkiewicz A, Banasiuk M. Influence of body position on defecation mechanics measured during high-resolution anorectal manometry in paediatric population: a protocol for case-control study. BMJ Open. 2025 Dec 31;15(12):e112928. doi: 10.1136/bmjopen-2025-112928. PubMed 41475818 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2020 to primary completion in Aug 2026, 79 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2024
First posted
Apr 13, 2025
StartActual
Jan 10, 2020
Primary completionActual
Aug 17, 2026
CompletionActual
Aug 17, 2026
Last update
Aug 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06924957
Collaborators
Medtronic
Responsible party
Marcin Banasiuk (MD PhD, Medical University of Warsaw) — Principal investigator
First posted
Apr 13, 2025
Start date
Jan 10, 2020
Primary completion
Aug 17, 2026
Completion
Aug 17, 2026
Last update
Aug 19, 2026

Study contacts

Barbara Skowrońska, MD
principal investigator · Department of Pediatric Gastroenterology Medical University of Warsaw

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion